<DOC>
	<DOCNO>NCT00003925</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase I trial study effectiveness combine gemcitabine , fluorouracil-uracil leucovorin treat patient advanced cancer respond previous therapy .</brief_summary>
	<brief_title>Combination Chemotherapy In Treating Patients With Advanced Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine maximum tolerated dos gemcitabine , fluorouracil-uracil ( UFT ) , leucovorin calcium patient advanced refractory cancer . - Assess toxicity combination regimen patient population . - Evaluate regimen term response rate , response duration , overall survival patient . OUTLINE : This dose escalation study gemcitabine fluorouracil-uracil . Patients receive gemcitabine IV 30 minute day 1 , 8 , 15 . Patients receive oral leucovorin calcium immediately follow oral fluorouracil-uracil ( UFT ) three time day day 1-21 . Courses repeat every 28 day . Treatment continue absence disease progression unacceptable toxicity . Cohorts 3-6 patient receive escalate dos gemcitabine UFT maximum tolerate dose ( MTD ) determine . The MTD define dose precede 2 6 patient experience dose limit toxicity . PROJECTED ACCRUAL : A total 36 patient accrue study .</detailed_description>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Tegafur</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm malignancy refractory exist chemotherapy standard therapy exist Evaluable disease PATIENT CHARACTERISTICS : Age : 18 Performance status : SWOG 02 Life expectancy : Greater 3 month Hematopoietic : Absolute neutrophil count great 1,500/mm3 Platelet count great 100,000/mm3 Hemoglobin great 8.0 mg/dL Hepatic : Bilirubin le 2.0 mg/dL AST le 3.0 time upper limit normal Renal : Creatinine great 2.0 mg/dL Other : No active infection require antibiotic Not pregnant nursing Fertile patient must use effective barrier contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 3 week since prior systemic cytotoxic chemotherapy ( include fluorouracil ) recover No prior gemcitabine Endocrine therapy : Prior hormonal therapy allow No concurrent hormonal contraception Radiotherapy : At least 3 week since prior radiotherapy large area active bone marrow recover Surgery : Prior major surgery allow recover Other : No prior concurrent antiviral nucleoside</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>